Abstract. It remains possible that chemicals that act by mutagenic mechanisms as well as chemicals that do not induce gene mutations may affect epigenetic gene expression. To test the possibility, we investigated the ability of both types of chemicals to alter the expression of five imprinted genes, PEG3, SNRPN, NDN, ZAC and H19, using two human colon cancer cell lines and a human breast cancer cell line.
Introduction
Normal development involves tissue specific regulation of gene expression by epigenetic mechanisms. Certain genes are imprinted early in development and display allele specific gene expression depending on the parent of origin. The mechanisms of epigenetic regulation of expression of imprinted genes are complex involving both DNA methylation and chromatin modification. In imprinted genes such as H19, cytosine methylation of the CpG sequences in the promoter region is dependent on the gender of the parent from which the allele was inherited, and reflects allele-specific gene transcription (1) . The expression of imprinted genes, which is suppressed by hypermethylation of promoter CpG sequences, can be restored by treatment with DNA methyltransferase inhibitors (2) . Mechanisms of epigenetic regulation during development of non-imprinted genes are less well understood although changes in DNA methylation and chromatin structure are among the possibilities. The accumulation of epigenetic abnormalities in embryonic cells and embryonic stem cells during culture, especially the accumulation of changes in the expression of imprinted genes is potentially related with abnormal development in cloned and chimeric animals (3) (4) (5) . The regulation of imprinted gene expression further highlights the role of epigenetic control of gene expression.
Epigenetic changes in gene expression are also important in malignant development (6) (7) (8) (9) (10) (11) (12) . Changes of the normal pattern of parental origin-specific gene expression or loss of imprinting (LOI) are associated with various cancers. LOI is the most common molecular alteration in Wilms' tumors, an embryonal kidney cancer (11) . LOI is also found commonly in most adult solid tumors, including colorectal, liver, and lung cancers, as well as in leukemia (11) . Silencing of imprinted genes is also observed in many cancers (6) .
The etiology of epigenetic changes in cancer is unknown. It is possible that chemical carcinogens may affect the expression of critical genes in the carcinogenesis process but methods to assess this potential activity of chemicals are lacking. Chemical carcinogens are often classified as mutagenic or non-mutagenic based on their ability to induce gene mutations in a variety of well-established assays (13) . However, it remains possible that chemicals that act by mutagenic mechanisms as well as chemicals that do not induce gene mutations may affect epigenetic gene expression. To test this idea, we examined the ability of 6 non-mutagenic and 3 mutagenic carcinogens to affect the expression of 5 imprinted genes in three human cancer cell lines. The reasons for use of established cell lines are: i) human cancer cell lines have been utilized for studying the correlation between epigenetic modifications and expression of imprinted genes (6, (8) (9) (10) 14) ; and ii) established cell lines have stable growth which is suitable for assessing the potential of chemicals to induce epigenetic modifications of imprinted genes with reproducible results. Our findings indicate that some chemical carcinogens of both classes can epigenetically influence the transcription levels of imprinted genes. In addition, we examined whether chemical carcinogens induced LOI in normal human fibroblasts to study the epigenetic carcinogenic effects of the chemicals.
Materials and methods
Cells and culture conditions. Human colorectal cancer cell lines (HTB-38 and CCL-247 cells), a human breast cancer cell line (HTB-22 cells), human immortal fibroblast cell lines [OUMS-24F cells (15) and LCS-AF.1-2 cells (16)], and a normal human fibroblast strain (WHE-7 cells) (17) were used in the present study. These cells were grown in Eagle's minimum essential medium containing 10% fetal bovine serum, 0.2 mM serine, 0.1 mM aspartic acid, 1.0 mM pyruvate, and 0.22% NaHCO 3 at 37˚C in a 5% CO 2 incubator. OUMS-24F cells were derived from a normal human fibroblast strain, OUMS-24 cells, which were immortalized by repeated treatments with 4-nitroquinoline 1-oxide (4-NQO) (15) . LCS-AF.1-2 cells were derived from a skin fibroblast strain, MDAH 087 cells, which were immortalized by aflatoxin B 1 in the presence of exogenous metabolic activation with rat liver post-mitochondrial supernatant (16, 17) .
Chemicals. Non-mutagenic carcinogens: diethylstilbestrol (DES) (Sigma, St. Louis, MO), reserpine (Wako Pure Chemical, Osaka, Japan), and cyclosporin A (Wako Pure Chemical) were dissolved in dimethylsulfoxide (DMSO) (Sigma); sodium arsenite (SAR) (Sigma), and chlorpromazine hydrochloride (Wako Pure Chemical) were dissolved in Ca 2+ -and Mg 2+ -free phosphate-buffered saline (PBS (-), Nissui Pharmaceutical, Tokyo, Japan) and filter-sterilized; nickel chloride hexahydrate (NiCl 2 ) (Sigma) was dissolved in ethanol. Mutagenic carcinogens: 4-NQO (Wako Pure Chemical) and melphalan (Wako Pure Chemical) were dissolved in DMSO; mitomycin C (MMC) (Wako Pure Chemical) was dissolved in PBS (-) and filter-sterilized. The DNA methyltransferase inhibitor, 5-aza-2'-deoxycytidine (5-AzaC) (Sigma) used as a positive control for inducing LOI of imprinted genes, was dissolved in 50% acetic acid. Ampicillin sodium (Wako Pure Chemical) and D-(-)-mannitol (Wako Pure Chemical), used as negative controls, were dissolved in PBS (-) and filtersterilized.
Determination of chemical concentrations. HTB-38 cells (1x10
3 ), CCL-247 cells (2.5x10 2 ), and HTB-22 cells (1x10 3 ) were plated on 96-well cell culture plates (Costar, Cambridge, MA) with 100 μl of medium and incubated overnight. Cells were treated with various concentrations of chemical carcinogens for 6 days during which medium was replenished every other day. The cells were washed once with PBS (-), and 125 μl of a mixture of 25 μl of CellTiter96 Aqueous One Solution (Promega, Madison, WI) and 100 μl of culture medium were added to the plates, which were incubated for 1 h at 37˚C in a 5% CO 2 incubator. The absorbance was recorded at 490 nm using a 96-well micro plate reader (Toso, Yamaguchi, Japan). The percentage of growth inhibition was determined from the absorbance of treatment group relative to the control x 100. Table I ). The PCR products were subjected to a 2% agarose gel or 6% polyacrylamide gel (for the ZAC gene) electrophoresis. The gels were stained with SYBR-Green I (Biowhittaker Molecular Applications, Rockland, ME) and analyzed by a fluorescence imaging analyzer (Luminescent image analyzer, LAS-1000 plus, Fuji film, Tokyo, Japan). We measured restoration of expression of non-expressed genes. We also scored loss of expression of expressed genes. In the present study, we referred to both as LOI. For imprinted genes with conserved expression in cells following treatment with chemical carcinogens, we scored the results as 'not clear', because we did not know whether the expression was monoallelic or biallelic.
Methylation specific PCR (MSP) assay. HTB-38 cells were plated into 75-cm 2 flasks, incubated overnight and treated for 6 days with SAR or MMC at the concentrations of IC 50 . Genomic DNAs were treated with sodium bisulfite by using the CpGenome™ DNA modification kit (Intergen, Purchase, NY) according to the manufacturer's instructions. MSP assay was performed to examine the methylation status of the CpG islands within the SNRPN promoter region which is from 96 bp upstream to 87 bp downstream of the transcription start site for methylated allele and from 99 bp upstream to 88 bp downstream of the transcription start site for unmethylated allele. The primers used were methylated forward 5'-CAA ACA AAC ACG CCT ACG CGA CCG-3', methylated reverse 5'-GGT ATA GTT GAT TTT GTT CGT TTT ATC GC-3', unmethylated forward 5'-CAA CAA ACA AAC ACA CCT ACA CAA CCA-3', and unmethylated reverse 5'-TGG TAT AGT TGA TTT TGT TTG TTT TAT TGT-3' [sequence from GenBank (accession number MIM 182279)]. The PCR conditions were 95˚C for 9 min; 35 cycles at 95˚C for 1 min, 62˚C or 69˚C for unmethylated or methylated alleles, respectively, for 1 min, and 72˚C for 3 min. The PCR products were purified using the MinElute PCR purification kit (Qiagen GmbH), and then sequenced by Espec Co. (Tsukuba, Japan).
Chromatin immunoprecipitation (ChIP) assay. HTB-38 cells were plated, incubated overnight and treated for 6 days with various chemicals at the concentrations of IC 50 . The ChIP assay was performed with a ChIP assay kit (Upstate Biotechnology, Lake Placid, NY) with anti-dimethyl-Histone H3 (Lys 9), anti-dimethyl-Histone H3 (Lys 4), or anti-acetylHistone H4, as described previously (19) . These antibodies were purchased from Upstate Biotechnology. Immunoprecipitated DNA was amplified with an advantage-GC genomic Table I . PCR primer sequences and PCR conditions. 
F, forward; R, reverse; GF, forward for genomic DNA; GCR, reverse for genomic and complementary DNA; CF, forward for complementary DNA; gDNA, genomic DNA; cDNA, complementary DNA.
polymerase mix (Clontech, Palo Alto, CA). The primers used for amplification of the promoter region of SNRPN which is from 54 bp upstream to 120 bp downstream of the transcription site (20) were sense, 5'-GAT GCT CAG GCG GGG ATG TGT GCG-3' and antisense, 5'-GCT CCC CAG GCT GTC TCT TGA GAG-3' (21). The PCR conditions were 94˚C for 10 min; 33 cycles at 94˚C for 30 sec, 65˚C for 30 sec, and 72˚C for 30 sec (21). CEN16 was used as the control PCR for DNA immunoprecipitated with methyl H3 Lys 9 (H3-K9) antibody and GAPDH was used as the control PCR for DNA immunoprecipitated with methyl H3 Lys 4 (H3-K4) and with acetyl H4. The primer sequences of CEN16 and GAPDH and the PCR conditions were the same as those described by Xin et al (20) and Kumakura et al (19) , respectively. The PCR products were subjected to a 2% agarose gel electrophoresis. The gels were stained and analyzed as described above.
Results

Determination of chemical concentrations for growth inhibition (IC 50 )
. Fig. 1 Table II . The concentrations of non-mutagenic or mutagenic carcinogens that induced a 50% inhibition of cellular growth in human cancer cell lines. 
DES, diethylstilbestrol; SAR, sodium arsenite; NiCI 2 , nickel chloride hexahydrate; MMC, mitomycin C; 4-NQO, 4-nitroquinoline 1-oxide.
- (Fig. 2B ).
All the results described above are summarized in Table III . Only gene activation of non-expressed imprinted genes and no gene silencing of expressed imprinted genes were observed in the present study. Because the results may be due to short treatment time or limited concentration range that was studied and may also be due to the fact that only imprinted genes were studied, we examined whether treatment with lower concentrations (50-100 μM) of NiCl 2 for a longer time (3 weeks) induced changes in expression of the imprinted gene, H19, and the non-imprinted genes, DHFR (dihydrofolate reductase) and hMLH1 (human MutL homolog 1: one of human DNA mismatch repair genes), using HTB-38 cells and a normal human fibroblast strain, WHE-7 cells. Treatment with 50-100 μM NiCl 2 for 2-3 weeks has previously been shown to silence the gpt (bacterial xanthine guanine phosphoribosyltransferase) transgene via epigenetic mechanisms in G12 Chinese hamster cells in concentration-and treatment time-dependent manners (21) . As shown in Fig. 2C , treatment of HTB-38 cells or WHE-7 cells with 50-100 μM NiCl 2 for 3 weeks did not silence any of these genes.
LOI following treatment of normal human fibroblasts with chemical carcinogens.
To examine whether LOI was induced by treatment of normal human fibroblasts with chemical 
-----------------------------------------------------------------------------------------------------
Black boxes, restoration of expression of non-expressed imprinted genes; grey boxes, no restoration of expression of non-expressed imprinted genes; white boxes, not clear because no evidence to know whether the expression of expressed imprinted genes is monoallelic or biallelic. Des, diethylstilbestrol; SAR, sodium arsenite; NICI 2 , nickel chloride hexahydrate; 5-AzaC, 5-aza-2'-deoxycytidine; MMC, mitomycin C, 4-NQO, 4-nitroquinoline 1-oxyde. (Fig. 2D) . Although the expression of SNRPN was conserved in human fibroblasts, LCS-AF.1-2 cells which were immortalized by treatment of a human fibroblast strain, MDAH 087 cells, with aflatoxin B 1 in the presence of exogenous metabolic activation, the expression of NDN was lost in the cells. Expression of the NDN gene was reactivated by 5-AzaC (Fig. 2D) .
----------------------------------------------------------------------------------------------------------------------
Methylation status of the CpG island in the SNRPN promoter region.
To examine the association of imprinted gene expression induced by non-mutagenic or mutagenic carcinogens with demethylation of DNA, we studied the methylation status of the CpG island in the promoter region of the gene by an MSP assay. In these experiments, we analyzed the CpG islands in the promoter region of the SNRPN gene in HTB-38 cells treated with SAR or MMC, because the promoter region was well characterized (22) . The SNRPN CpG island was methylated in the control HTB-38 cells (Fig. 3) . Weak and strong signals showing the unmethylated or methylated SNRPN CpG island, respectively, were observed in HTB-38 cells treated with SAR. Both signals exhibiting the unmethylated and methylated CpG islands were also observed in the cells treated with 5-AzaC. These results indicate that the CpG island of the SNRPN promoter in HTB-38 cells treated with SAR was partially methylated. The states of methylation of the CpG island were confirmed by the sequencing of MSP products where the CpG cytosines which lie from 60 bp upstream to 87 bp downstream of the transcription start site were largely methylated in the control HTB-38 cells and partially methylated in HTB-38 cells treated with SAR (Fig. 3) . Conversely, HTB-38 cells treated with MMC had a signal only showing the methylated CpG island (Fig. 3) .
ChIP assay at the SNRPN promoter. Because a difference in the methylation status of the SNRPN CpG island was found between the control HTB-38 cells and HTB-38 cells treated with SAR or 5-AzaC, we performed ChIP assay of the patterns of both methylations of histone H3 lysine 9 (H3-K9) and histone H3 lysine 4 (H3-K4) and acetylation of histone H4 to examine the possible involvement of chromatin states in the transcriptional regulation of the SNRPN promoter. Methylation of H3-K4 and acetylation of histone H4 are well known to be associated with an open chromatin configuration such as that found at transcriptionally active promoters. In contrast, methylation of H3-K9 is a marker of condensed, inactive chromatin (23, 24) . As shown in Fig. 4A , the SNRPN CpG island in HTB-38 cells treated with SAR or 5-AzaC had a lower or similar level, respectively, of H3-K9 methylation of the SNRPN CpG island compared with that in the control HTB-38 cells. Conversely, the SNRPN CpG island in HTB-38 cells treated with SAR or 5-AzaC exhibited higher levels of H3-K4 methylation compared with that in the control cells (Fig. 4B) . In addition, the levels of acetylation of histone H4 were greater in HTB-38 cells treated with SAR or 5-AzaC than in the control cells (Fig. 4C) .
Discussion
Chromatin structure plays an important role in epigenetic gene regulation, and hypermethylation of CpG sequences in promoter regions silences gene transcription (19, 25, 26) . Furthermore, a methyl-CpG binding protein forms a complex with a histone deacetylase and modifies chromatin structure by deacetylating histone, which leads to transcriptional repression (27) (28) (29) . The expression of imprinted genes can be influenced by a DNA methyltransferase inhibitor or a histone deacetylase inhibitor (30) (31) (32) (33) . The DNA methyltransferase inhibitor, 5-AzaC, activated the expression of all of the nonexpressed imprinted genes in the 3 human cancer cell lines used in the present study. Chemical carcinogens that affect the expression of imprinted genes have the potential to cause epigenetic modifications of cancer-related genes in human cells. Indeed, we demonstrated that human fibroblasts immortalized by either 4-NQO or aflatoxin B 1 exhibited loss of expression of the imprinted genes, PEG3 and NDN. The gene expressions lost in the immortal cells were restored by treatment with 5-AzaC. In addition, we previously demonstrated that human fibroblasts immortalized by aflatoxin B 1 exhibited gain of the imprinted gene, ZNF127 (15) . These immortal cells also exhibited loss of p16 INK4a protein expression by hypermethylation of CpG islands within the promoter region of INK4a (18) . Furthermore, human fibroblasts immortalized by infection with a retrovirus vector encoding the human telomerase catalytic subunit (hTERT) lost the expression of imprinted genes (PEG3, NDN and/or MAGE-L2) as well as INK4a by hypermethylation of the promoter (18) .
Among the 9 chemicals examined, 4 non-mutagenic carcinogens, DES, SAR, NiCl 2 , and chlorpromazine, and 2 mutagenic carcinogens, MMC and 4-NQO, induced expression of PEG3, SNRPN, NDN, or ZAC in the 3 cell lines. The nonexpressed imprinted genes in these cancer cell lines were activated by these carcinogens independent of their mutagenic activity, suggesting that the mechanism of epigenetic effects is different from the mechanism for DNA mutation. The epigenetic effects of these carcinogens, particularly nonmutagenic carcinogens, may be involved in transformation of normal cells.
The genes activated by the chemicals varied among individual cell lines. One possibility for this heterogeneity may be differences in the ability of chemicals to inhibit DNA methyltransferase. 5-AzaC induced the restoration of expression of all of the non-expressed imprinted genes in the 3 cell lines. 5-AzaC selectively degrades the maintenance DNA methyltransferase, DNMT1, by a proteasomal pathway and this process requires a functional ubiquitin-activating enzyme (E1) (34) . Chemical carcinogens with higher activity for E1 may have the potential to induce a more pronounced degradation of DNMT1 and reactivate silenced genes. Only gene activation and no gene silencing were observed in the present study. This may be due to a difference of imprinted genes and a type of cells examined because some chemical carcinogens induced both loss and gain of expressions of various imprinted genes in human fibroblasts. Chen et al (21) reported that treatment with low concentrations of NiCl 2 for ling times silenced the gpt transgene via epigenetic mechanisms in G12 Chinese hamster cells. Thus, we examined whether long-term treatment of HTB-38 cells or normal human fibroblasts with low concentrations of NiCl 2 silenced the imprinted gene, H19, and the non-imprinted genes, DHFR and hMLH1. However, treatment of HTB-38 cells or normal human fibroblasts with 50-100 μM NiCl 2 for 3 weeks failed to silence both genes.
The imprinted genes most commonly influenced by the active chemical carcinogens were PEG3 and SNRPN. It is noteworthy that a high frequency of loss of expression of PEG3 and NDN is observed in human cells immortalized either spontaneously or by viral oncogenes or chemical or physical carcinogens, suggesting that non-random imprinted genes may be affected by these carcinogens.
It has been reported that in paternally inherited imprinted genes, hypermethylation of H3-K9 and hypomethylation of H3-K4 of the chromatin containing the promoters are associated with gene silencing (20) . The patterns of methylations of H3-K9 and H3-K4 and the acetylation status of H3-K9 and H3-K14 are linked to chromatin remodeling as well as transcriptional regulation (35, 36) . Chemical carcinogens may influence posttranslational modification of histone proteins that could influence the expression of imprinted genes. In the present study, we demonstrated with MSP assays that restoration of expression of the non-expressed imprinted gene SNRPN was associated with hypomethylation of the CpG island of the SNRPN promoter in SAR-treated cells but not in MMC-treated cells. Hypomethylation of H3-K9 and hypermethylation of H3-K4 methylation as well as increased levels of histone H4 acetylation of the chromatin containing the SNRPN promoter were observed in SAR-treated cells, indicating that SAR, but not MMC, can induce hypomethylation of the SNRPN promoter and euchromatinization of the heterochromatic domains of the promoter. These results suggest the possibility that changes in the SNRPN expression induced by SAR may be associated with the chromatin structure-mediated regulation of SNRPN promoter. MSP and ChIP assays are being performed at the other promoters where chemical treatment resulted in a change in expression.
MMC is a direct-acting carcinogen and induces both intra-and interstrand DNA crosslinks that block key DNA metabolisms including DNA replication and transcription in MMC-treated cells (37) . To our knowledge, there are no reports on the induction of altered expression of imprinted genes by MMC. Although the mechanisms remain to be clarified, MMC may induce expression of non-expressed imprinted genes by a mechanism other than hypomethylation of the CpG island in the promoter region of the genes.
Both non-mutagenic and mutagenic carcinogens, including DES, SAR, NiCl 2 , MMC and 4-NQO, affected the expression of the specific imprinted genes in human cancer cell lines.
Hypomethylation in exon-4 of the c-fos, one of the key players in uterine carcinogenesis after estrogen stimulation, and elevated expression of c-fos are observed in mouse uterus upon neonatal exposure to DES, although the direct correlation between c-fos exon-4 hypomethylation and the elevation of its mRNA level remains unclear (38) . Arsenic induces CpG island demethylation of tumor suppressor genes by inhibition of DNA methyltransferase and reactivates the silenced genes in human liver cancer cells (39) . Arsenic also induces hypomethylation of proto-oncogenes leading to malignant transformation in mammalian cells (40, 41) . Nickel ions are involved in both DNA methylation and histone deacetylation (42, 43) . Although the mechanism by which nickel ions induced the restoration of expression of nonexpressed imprinted genes is unclear, Chen et al (21) have reported that nickel ions decrease the expression and activity of histone H3K9 specific methyltransferase G9a. Because the quinoline-based compound, designated S1027, causes selective degradation of DNMT1 in human cancer cells with minimal or no effects on DNMT3A and DNMT3B by a proteasomal pathway (Datta J, et al, Am Assoc Cancer Res Proc CD-ROM 48: abs. 4142, 2007), 4-NQO, one of the quinoline derivatives, can induce degradation of DNMT1 and re-express the non-expressed imprinted genes shown in the present study.
In summary, our findings indicate that, in cancer cells, some mutagenic or non-mutagenic carcinogens can epigenetically influence the transcription levels of imprinted genes. Because some chemical carcinogens affected the expression of not only imprinted genes but cancer-related genes in normal human cells, our results also suggest the possibility that some chemical carcinogens may have epigenetic carcinogenic effects in human cells.
